prokineticin-1



prokineticin-1

A1AA1V2VV2I3II3T4TT4G5GG5A6AA6C7CC7E8EE8R9RR9D10DD10V11VV11Q12QQ12C13CC13G14GG14A15AA15G16GG16T17TT17C18CC18C19CC19A20AA20I21II21S22SS22L23LL23W24WW24L25LL25R26RR26G27GG27L28LL28R29RR29M30MM30C31CC31T32TT32P33PP33L34LL34G35GG35R36RR36E37EE37G38GG38E39EE39E40EE40C41CC41H42HH42P43PP43G44GG44S45SS45H46HH46K47KK47... and 39 more residue(s)...... and 39 more residue(s)

SMILES None
InChIKey None
Sequence AVITGACERDVQCGAGTCCAISLWLRGLRMCTPLGREGEECHPGSHKVPFFRKRKHHTCPCLPNLLCSRFPDGRYRCSMDLKNINF

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

prokineticin-1

A1AA1V2VV2I3II3T4TT4G5GG5A6AA6C7CC7E8EE8R9RR9D10DD10V11VV11Q12QQ12C13CC13G14GG14A15AA15G16GG16T17TT17C18CC18C19CC19A20AA20I21II21S22SS22L23LL23W24WW24L25LL25R26RR26G27GG27L28LL28R29RR29M30MM30C31CC31T32TT32P33PP33L34LL34G35GG35R36RR36E37EE37G38GG38E39EE39E40EE40C41CC41H42HH42P43PP43G44GG44S45SS45H46HH46K47KK47... and 39 more residue(s)...... and 39 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.